| Date Filed | Type | Description |
| 08/24/2023 |
4
| Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $0.33, valued at
$33k
|
|
| 08/23/2023 |
4
| Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Bought 200,000 shares
@ $0.322, valued at
$64.4k
|
|
| 02/14/2023 |
5
| Javitt Jonathan C (10% Owner) has filed a Form 5 on NRX Pharmaceuticals, Inc. |
| 12/09/2022 |
4
| Javitt Jonathan C (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Sold 400,000 shares
@ $1, valued at
$400k
|
|
| 06/17/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/03/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/02/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2021 |
SC 13D/A
| Javitt Jonathan C reports a 48.2% stake in NRX Pharmaceuticals, Inc. |
| 06/10/2021 |
4
| Javitt Jonathan C (CEO) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 46,332 shares
@ $0
Granted 13,348,997 shares
@ $0
Granted 1,422,000 shares
@ $0 |
|
| 06/10/2021 |
3
| Javitt Jonathan C (CEO) has filed a Form 3 on NRX Pharmaceuticals, Inc. |
| 06/03/2021 |
SC 13D
| Javitt Jonathan C reports a 60.7% stake in NRX Pharmaceuticals, Inc. |
| 03/09/2009 |
4/A
| Javitt Jonathan C (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC |
| 03/05/2009 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |